Factor XII Antibodies

Santa Cruz Biotechnology offers a broad range of Factor XII Antibodies for research in coagulation and hemostasis. Factor XII Antibodies are available for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Factor XII, also known as Hageman factor, plays a crucial role in the intrinsic pathway of blood coagulation, initiating the cascade that leads to clot formation. Factor XII activation is essential for the regulation of fibrinolysis and inflammation, making it a significant target for understanding thrombotic disorders and developing therapeutic interventions. Research on Factor XII can provide insights into various pathological conditions, including cardiovascular diseases and certain bleeding disorders. Factor XII studies have revealed important mechanisms in blood coagulation pathways and their regulation. Understanding Factor XII function has implications for developing new approaches to treating coagulation disorders. Factor XII monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of blood coagulation and related diseases.